Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit. Read More

A Staggering Number of U.S. Adults Are Eligible for Ozempic, Study Finds

A study published this past October, for instance, estimated that higher uptake of GLP-1 drugs could prevent 42,000 deaths annually in the U.S. from obesity- or diabetes-related health problems. Read More

Ozempic Users Had Up To 70 Percent Lower Alzheimer’s Risk. Doctors Explain The Science.

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 percent lower in patients who took semaglutide compared to those who took ... Read More

Ozempic May Curb Alcohol Addiction, New Study Finds: Here's Why - MSN

New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues. More than 28 million adults in the U.S. struggle with alcohol ... Read More

New study finds Ozempic may be linked with a form of blindness

A new study explored the potential visual health risks associated with semaglutide-based weight loss drugs like Ozempic and Wegovy. Read More

New Study Finds Ozempic May Do More than What We Originally Thought - MSN

A new study finds the drug semaglutide, or more commonly known under the names Ozempic, Wegovy and Monjaro, may do more than promote feelings of fullness by suppressing appetite, it may also ... Read More

More Than Half of U.S. Adults Could Be Candidates for Ozempic

TUESDAY, Nov. 19, 2024 (HealthDay News) -- More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds. Read More

Tariffs make consumers take a wait-and-see spending approach

Trump's tariffs could spell the end of the resilient consumer, a new study says. Read More

Ozempic shows promise for alcohol and drug addiction, study finds

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too. Read More

More Ozempic users doubt they can keep weight off without drug: Study

Only two in five people taking GLP-1 medication were confident they would maintain their weight loss after stopping the regimen, the survey found. Read More

Drugs used for weight loss help people stop smoking, study finds

Semaglutide, the active ingredient in drugs like Wegovy and Ozempic , can help people lose weight — and a new study says it may also help people quit smoking . Read More

Ozempic May Curb Alcohol Addiction, New Study Finds: Here's Why

A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related hospitalizations. Here's what to know. Read More